KM Financial Solutions | UPDATE 2-GSK buys Novartis stake in consumer healthcare venture for $13 bln
13222
post-template-default,single,single-post,postid-13222,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

UPDATE 2-GSK buys Novartis stake in consumer healthcare venture for $13 bln

UPDATE 2-GSK buys Novartis stake in consumer healthcare venture for $13 bln

ZURICH, March 27 (Reuters) – GlaxoSmithKline said on
Tuesday it will buy Novartis’s 36.5 percent stake in
their consumer healthcare joint venture for $13 billion in cash,
and will also begin a strategic review of some other businesses.

No Comments

Sorry, the comment form is closed at this time.